Benzinga's Top Pre-Market Gainers

MannKind MNKD moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA. Brocade Communications BRCD soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results. Osiris Therapeutics OSIR surged 9% to $27.73 in the pre-market session on clinical study results. GenMark Diagnostics GNMK shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.